X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
Details:
SP-002 is a biologic therapeutic based on an adenovirus, that has been engineered to produce the immunostimulatory anti-cancer protein, Interferon-g. It is being investigated in combination with vismodegib for treating locally advanced and metastatic basal cell carcinoma.
Lead Product(s): SP-002,Vismodegib
Therapeutic Area: Oncology Product Name: SP-002
Highest Development Status: Phase IIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 11, 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
